Chi-Un Pae, MD

Cognitive Dysfunction in Psychiatric Illness: A Neglected Domain

March 25, 2015

Article

A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease

August 15, 2014

Here, review results from a 10-week study that compared the pain-relieving effects of milnacipran, an SNRI, to that of placebo in patients with lumbosacral disc disease. Nerve pain in...

David M. Marks, Chi-Un Pae, Ashwin A. Patkar

Original Research

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

May 15, 2012

Chi-Un Pae, J. Alexander Bodkin, Kimberly Blanchard Portland, et al

Letter to the Editor

Augmentation of Dopaminergic Agents for Major Depressive Disorder

May 15, 2009

Chi-Un Pae, Ashwin A. Patkar, Prakash S. Masand

Original Research

History of Depressive and Anxiety Disorders and Paroxetine Response in Patients With Irritable Bowel Syndrome: Post Hoc Analysis From a Placebo-Controlled Study

October 15, 2008

David M. Marks, Changsu Han, Stan Krulewicz, et al

Original Research

An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features

June 16, 2008

Chi-Un Pae, Prakash S. Masand, Kathleen Peindl, et al

Original Research

Rapid Versus Conventional Initiation of Quetiapine in the Treatment of Schizophrenia: A Randomized, Parallel-Group Trial

March 15, 2007

Chi-Un Pae, Chang-Uk Lee, Soo-Jung Lee, et al

Original Research

Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone

May 12, 2002

Kwang-Soo Kim, Chi-Un Pae, Jeong-Ho Chae, et al

Cognitive Dysfunction in Psychiatric Illness: A Neglected Domain

A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

Augmentation of Dopaminergic Agents for Major Depressive Disorder

History of Depressive and Anxiety Disorders and Paroxetine Response in Patients With Irritable Bowel Syndrome: Post Hoc Analysis From a Placebo-Controlled Study

An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features

Rapid Versus Conventional Initiation of Quetiapine in the Treatment of Schizophrenia: A Randomized, Parallel-Group Trial

Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone

ELSEWHERE:

FOLLOW US:

Chi-Un Pae, MD

Cognitive Dysfunction in Psychiatric Illness: A Neglected Domain

A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease

Safety of Selegiline Transdermal System in Clinical Practice: Analysis of Adverse Events From Postmarketing Exposures

Augmentation of Dopaminergic Agents for Major Depressive Disorder

History of Depressive and Anxiety Disorders and Paroxetine Response in Patients With Irritable Bowel Syndrome: Post Hoc Analysis From a Placebo-Controlled Study

An Open-Label, Rater-Blinded, Flexible-Dose, 8-Week Trial of Escitalopram in Patients With Major Depressive Disorder With Atypical Features

Rapid Versus Conventional Initiation of Quetiapine in the Treatment of Schizophrenia: A Randomized, Parallel-Group Trial

Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles